This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Abstract Details
|
Activity Number:
|
372
|
|
Type:
|
Roundtables
|
|
Date/Time:
|
Tuesday, August 3, 2010 : 12:30 PM to 1:50 PM
|
|
Sponsor:
|
Section on Risk Analysis
|
| Abstract - #309467 |
|
Title:
|
Some Issues in Risk Analysis of Drug Products
|
|
Author(s):
|
Tony Lachenbruch*+
|
|
Companies:
|
Oregon State University
|
|
Address:
|
College of Health and Human Sciences, Corvallis, OR, 97331,
|
|
Keywords:
|
Drug effectiveness ;
Spurious Side Effects ;
Vaccines and Autism
|
|
Abstract:
|
We will discuss issues of risk in the drug approval process, and in communicating the issues to the public. One of the common problems is the assumption by the public that all drugs submitted to the FDA are effective, so why is the FDA dragging its feet? Another problem arises when a small group is certain that a drug causes a certain side effect, but scientific evidence shows no such thing. The problem with Vaccines and Autism is a case in point. Participants in the roundtable will discuss these and other issues of interest.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2010 program
|
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.